YANG; Zhi-Yong

Patent Applications and Registrations

Patent applications and USPTO patent grants for YANG; Zhi-Yong.The latest application filed is for "bivalent, bispecific binding proteins for prevention or treatment of hiv infection".

Company Profile

12.33.48

YANG; Zhi-Yong - Bridgewater NJ
YANG; Zhi-Yong - Newton MA
Yang; Zhi-yong - Potomac MD
Yang; Zhi Yong - Shenzhen CN
Yang; Zhi-Yong - Potamac MD
Yang; Zhi-Yong - Ann Arbor MI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bivalent, Bispecific Binding Proteins For Prevention Or Treatment Of Hiv Infection App 20220226495 - YANG; Zhi-Yong ; et al.	2022-07-21
Expression Of Antigen-binding Proteins In The Nervous System App 20220213506 - ELMER; Bradford ; et al.	2022-07-07
Trispecific And/or Trivalent Binding Proteins App 20220119553 - YANG; Zhi-Yong ; et al.	2022-04-21
Trispecific and/or trivalent binding proteins Grant 11,192,960 - Yang , et al. December 7, 2	2021-12-07
Anti-CD38 antibodies and methods of use Grant 11,186,649 - Wu , et al. November 30, 2	2021-11-30
Bivalent, bispecific binding proteins for prevention or treatment of HIV infection Grant 11,129,905 - Yang , et al. September 28, 2	2021-09-28
Trispecific And/or Trivalent Binding Proteins App 20210061925 - YANG; Zhi-Yong ; et al.	2021-03-04
Trispecific and/or trivalent binding proteins Grant 10,882,922 - Yang , et al. January 5, 2	2021-01-05
Trispecific Binding Proteins, Methods, And Uses Thereof App 20200399369 - ASOKAN; Mangaiarkarasi ; et al.	2020-12-24
Broadly neutralizing HIV-1 antibodies that bind to the CD4-binding site of the envelope protein Grant 10,815,295 - Kwong , et al. October 27, 2	2020-10-27
Trispecific Anti-cd38, Anti-cd28, And Anti-cd3 Binding Proteins And Methods Of Use For Treating Viral Infection App 20200140552 - WU; Lan ; et al.	2020-05-07
Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of Hiv Infection App 20200054765 - YANG; Zhi-Yong ; et al.	2020-02-20
Data transmission method and apparatus Grant 10,547,999 - Qi , et al. Ja	2020-01-28
Anti-cd38 Antibodies And Methods Of Use App 20190106504 - WU; Lan ; et al.	2019-04-11
Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of Hiv Infection App 20190054182 - YANG; Zhi-Yong ; et al.	2019-02-21
Broadly Neutralizing Hiv-1 Antibodies That Bind To The Cd4-binding Site Of The Envelope Protein App 20190016786 - Kwong; Peter D. ; et al.	2019-01-17
Data Transmission Method And Apparatus App 20180324575 - QI; Sui Peng ; et al.	2018-11-08
Neutralizing antibodies to HIV-1 and their use Grant 10,035,845 - Mascola , et al. July 31, 2	2018-07-31
Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein Grant 10,035,844 - Kwong , et al. July 31, 2	2018-07-31
Neutralizing Antibodies To Hiv-1 And Their Use App 20170369558 - Mascola; John ; et al.	2017-12-28
Trispecific And/or Trivalent Binding Proteins App 20170320967 - YANG; Zhi-Yong ; et al.	2017-11-09
HIV-1 broadly neutralizing antibodies Grant 9,796,774 - Mascola , et al. October 24, 2	2017-10-24
Neutralizing Antibodies To Hiv-1 And Their Use App 20170267748 - Kwong; Peter D. ; et al.	2017-09-21
Neutralizing antibodies to HIV-1 and their use Grant 9,738,703 - Mascola , et al. August 22, 2	2017-08-22
Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein Grant 9,695,230 - Kwong , et al. July 4, 2	2017-07-04
Novel Hiv -1 Broadly Neutralizing Antibodies App 20160289305 - Mascola; John ; et al.	2016-10-06
HIV-1 broadly neutralizing antibodies Grant 9,382,311 - Mascola , et al. July 5, 2	2016-07-05
Neutralizing Antibodies To Hiv-1 And Their Use App 20160009789 - Mascola; John ; et al.	2016-01-14
Neutralizing antibodies to HIV-1 and their use Grant 9,175,070 - Mascola , et al. November 3, 2	2015-11-03
Nucleic acids encoding modified Ebola virus glycoproteins with diminished cytotoxicity while retaining native antigenic structures Grant 9,012,618 - Sullivan , et al. April 21, 2	2015-04-21
Neutralizing Antibodies To Hiv-1 And Their Use App 20140322163 - Kwong; Peter D. ; et al.	2014-10-30
Neutralizing antibodies to HIV-1 and their use Grant 8,637,036 - Mascola , et al. January 28, 2	2014-01-28
Novel Hiv -1 Broadly Neutralizing Antibodies App 20130251726 - Mascola; John ; et al.	2013-09-26
Method for inducing a multiclade immune response against HIV utilizing a multigene and multiclade immunogen Grant 8,454,972 - Nabel , et al. June 4, 2	2013-06-04
HIV vaccines based on adenoviral vectors encoding Env from multiple clades of HIV Grant 8,323,961 - Nabel , et al. December 4, 2	2012-12-04
Neutralizing Antibodies To Hiv-1 And Their Use App 20120282264 - Mascola; John R. ; et al.	2012-11-08
Neutralizing Antibodies To Hiv-1 And Their Use App 20120244166 - Mascola; John R. ; et al.	2012-09-27
Neutralizing Antibodies To Hiv-1 And Their Use App 20120237523 - Mascola; John R. ; et al.	2012-09-20
Nucleic Acid Sequences Encoding Expandable Hiv Mosaic Proteins App 20120219583 - Nabel; Gary J. ; et al.	2012-08-30
Protection Against Pandemic And Seasonal Strains Of Influenza App 20120219584 - Nabel; Gary J. ; et al.	2012-08-30
Optimized Vaccines To Provide Protection Against Ebola And Other Viruses App 20120156239 - Sullivan; Nancy ; et al.	2012-06-21
Development of a preventive vaccine for filovirus infection in primates Grant 8,124,592 - Nabel , et al. February 28, 2	2012-02-28
Antigenic Cloaking And Its Use App 20120034254 - Kwong; Peter D. ; et al.	2012-02-09
Development of a preventive vaccine for filovirus infection in primates Grant 8,106,027 - Nabel , et al. January 31, 2	2012-01-31
Development of a preventive vaccine for filovirus infection in primates Grant 8,106,026 - Nabel , et al. January 31, 2	2012-01-31
Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) angola glycoprotein gene insert and method of immunization employing said vector Grant 8,101,739 - Sullivan , et al. January 24, 2	2012-01-24
Hiv Vaccines Based On Env Of Multiple Clades Of Hiv App 20110274721 - Nabel; Gary J. ; et al.	2011-11-10
Method For Improving The Breadth Of The Immune Response To Diverse Strains And Clades Of Hiv App 20110200636 - Nabel; Gary J. ; et al.	2011-08-18
Dna Prime/activated Vaccine Boost Immunization To Influenza Virus App 20110177122 - Nabel; Gary J. ; et al.	2011-07-21
Influenza Dna Vaccination And Methods Of Use Thereof App 20110171260 - RAO; SRINIVAS ; et al.	2011-07-14
HIV vaccines based on Env of multiple clades of HIV Grant 7,947,822 - Nabel , et al. May 24, 2	2011-05-24
Development Of A Preventive Vaccine For Filovirus Infection In Primates App 20100303857 - Nabel; Gary J. ; et al.	2010-12-02
Development Of A Preventive Vaccine For Filovirus Infection In Primates App 20100297171 - Nabel; Gary J. ; et al.	2010-11-25
Development Of A Preventive Vaccine For Filovirus Infection In Primates App 20100298414 - Nabel; Gary J. ; et al.	2010-11-25
Hiv Vaccines Based On Env Of Multiple Clades Of Hiv App 20100111998 - Nabel; Gary J. ; et al.	2010-05-06
Avian Influenza Vaccine App 20100074916 - Nabel; Gary J. ; et al.	2010-03-25
Epitope-transplant Scaffolds And Their Use App 20100068217 - Kwong; Peter D. ; et al.	2010-03-18
HIV vaccines based on Env of multiple clades of HIV Grant 7,666,427 - Nabel , et al. February 23, 2	2010-02-23
Development of a preventive vaccine for filovirus infection in primates Grant 7,635,688 - Nabel , et al. December 22, 2	2009-12-22
Optimzed vaccines to provide protection against ebola and other viruses App 20090232841 - Sullivan; Nancy ; et al.	2009-09-17
Vaccines against aids comprising cmv/r-nucleic acid constructs App 20090214588 - Nabel; Gary J. ; et al.	2009-08-27
Antiviral Agents And Vaccines Against Influenza App 20090208531 - Nabel; Gary J. ; et al.	2009-08-20
HIV vaccines based on Env of multiple clades of HIV App 20080286306 - Nabel; Gary J. ; et al.	2008-11-20
Methods for coating stents with DNA and expression of recombinant genes from DNA coated stents in vivo App 20080112997 - Nabel; Elizabeth G. ; et al.	2008-05-15
Methods for treating cancers and restenosis with P21 App 20080095835 - Nabel; Gary J. ; et al.	2008-04-24
HIV vaccines based on Env of multiple clades of HIV App 20060275897 - Nabel; Gary J. ; et al.	2006-12-07
Methods for treating cancers and restenosis with p21 App 20060239975 - Nabel; Gary J. ; et al.	2006-10-26
Development of a preventive vaccine for filovirus infection in primates Grant 7,094,598 - Nabel , et al. August 22, 2	2006-08-22
Combination for site-specifically transforming cells in vivo comprising a double-balloon catheter and nucleic acid comprising a gene encoding P21 Grant 7,087,582 - Nabel , et al. August 8, 2	2006-08-08
Development Of A Preventive Vaccine For Filovirus Infection In Primates App 20060148087 - Nabel; Gary J. ; et al.	2006-07-06
Targeting gene transfer vectors to certain cell types by pseudotyping with viral glycoprotein App 20050130129 - Nabel, Gary J. ; et al.	2005-06-16
Methods for coating stents with DNA and expression of recombinant genes from DNA coated stents in vivo App 20050038499 - Nabel, Elizabeth G. ; et al.	2005-02-17
Development of a preventive vaccine for filovirus infection in primates App 20040259825 - Nabel, Gary ; et al.	2004-12-23
Methods for coating stents with DNA and expression of recombinant genes from DNA coated stents in vivo Grant 6,818,016 - Nabel , et al. November 16, 2	2004-11-16
Methods for treating restenosis with p21 Grant 6,218,372 - Nabel , et al. April 17, 2	2001-04-17
Methods for treating cancers and restenosis with P21 Grant 5,863,904 - Nabel , et al. January 26, 1	1999-01-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.